211 related articles for article (PubMed ID: 12948278)
1. Pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
Chulavatnatol S; Chindavijak B; Chierakul N; Klomsawat D
J Med Assoc Thai; 2003 Aug; 86(8):781-8. PubMed ID: 12948278
[TBL] [Abstract][Full Text] [Related]
2. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
Chierakul N; Klomsawat D; Chulavatnatol S; Chindavijak B
Int J Tuberc Lung Dis; 2001 Mar; 5(3):278-82. PubMed ID: 11326828
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of levofloxacin in healthy Thai male volunteers.
Chulavatnatol S; Chindavijak B; Vibhagool A; Wananukul W; Sriapha C; Sirisangtragul C
J Med Assoc Thai; 1999 Nov; 82(11):1127-35. PubMed ID: 10659548
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis.
Lee HW; Kim DW; Park JH; Kim SD; Lim MS; Phapale PB; Kim EH; Park SK; Yoon YR
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1161-6. PubMed ID: 19723408
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
6. Serum pharmacokinetics of antimycobacterial drugs in patients with multidrug-resistant tuberculosis during therapy.
Yew WW; Cheung SW; Chau CH; Chan CY; Leung CK; Cheng AF; Wong CF
Int J Clin Pharmacol Res; 1999; 19(3):65-71. PubMed ID: 10761535
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
Ye Z; Pei X; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811
[TBL] [Abstract][Full Text] [Related]
9. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
Conte JE; Golden JA; McIver M; Little E; Zurlinden E
Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of three antituberculous drugs in serum and cold abscesses of patients with spinal tuberculosis].
Wu Q; Duan L; Lin Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):617-9. PubMed ID: 11477883
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ofloxacin in broiler chicken.
Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
[TBL] [Abstract][Full Text] [Related]
14. Ofloxacin in multidrug resistant tuberculosis.
Walwaikar PP; Morye VK; Gawde AS
J Indian Med Assoc; 2003 Mar; 101(3):210-2. PubMed ID: 14603981
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of levofloxacin after single and multiple oral doses in patients undergoing intermittent haemodialysis.
Tsaganos T; Kouki P; Digenis P; Giamarellou H; Giamarellos-Bourboulis EJ; Kanellakopoulou K
Int J Antimicrob Agents; 2008 Jul; 32(1):46-9. PubMed ID: 18534825
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, tissue residue and plasma protein binding of ofloxacin in goats.
Baruah H; Roy DC; Roy RK; Khonikor HN
J Vet Sci; 2004 Jun; 5(2):97-101. PubMed ID: 15192335
[TBL] [Abstract][Full Text] [Related]
17. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report.
Berning SE; Cherry TA; Iseman MD
Clin Infect Dis; 2001 Feb; 32(4):643-6. PubMed ID: 11181130
[TBL] [Abstract][Full Text] [Related]
18. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
Conte JE; Golden JA; McIver M; Zurlinden E
Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
[TBL] [Abstract][Full Text] [Related]
19. [Determination of levofloxacin in plasma and cerebrospinal fluid with HPLC and its pharmacokinetics in patients undergoing neurosurgical operations].
Luo S; Lei J; Zhang R; Cai H; Li R
Yao Xue Xue Bao; 1998 Dec; 33(12):937-40. PubMed ID: 12016861
[TBL] [Abstract][Full Text] [Related]
20. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
Alffenaar JW; Kosterink JG; van Altena R; van der Werf TS; Uges DR; Proost JH
Ther Drug Monit; 2010 Feb; 32(1):97-101. PubMed ID: 20042919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
